Bronchitis Treatment - Global Market Outlook (2015-2022)

Bronchitis Treatment - Global Market Outlook (2015-2022)

  • Published: March 2016
  • ID: SMRC15599

According to Stratistics MRC, the Global Bronchitis Treatment Market accounted for $XX million in 2015 and is expected to grow at a CAGR of XX% to reach $XX million by 2022. Sedentary lifestyle, chemical pollutants, strict regulations to pollutant emission control, habit to cigarette smoke and adherence to a variety of international protocol are the major factors driving the market growth. Chemicals, smoke, air pollution and irritants are the risk factors for bronchitis. The most important indication of bronchitis is headache, continuous cough, nasal congestion, sore throat and fatigue.

Some of the key players in the market include GlaxoSmithKline Pharmaceuticals Limited, Boehringer Ingelheim, Osiris Therapeutics, Inc., Pfizer Inc., Reddy’s Laboratories Ltd, Sanofi Aventis, Hyundai Pharmaceutical Co., Ltd., Mucosis B.V. , Myelo Therapeutics GmbH, DBV Technologies S.A., Recipharm and Dr. Reddy’s Laboratories Ltd.

Class of Drugs Covered:
• Bronchodilators
• Mucolytics
• Antibiotics
• Anti-inflammatory Drugs

Treatments Covered:
• Oxygen therapy
• Drugs

End Users Covered:
• Drug stores
• Hospitals
• Clinics

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain 
o Rest of Europe     
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific   
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary       
         
2 Preface  
      
 2.1 Abstract       
 2.2 Stake Holders      
 2.3 Research Scope      
 2.4 Research Methodology      
  2.4.1 Data Mining     
  2.4.2 Data Analysis     
  2.4.3 Data Validation     
  2.4.4 Research Approach     
 2.5 Research Sources      
  2.5.1 Primary Research Sources    
  2.5.2 Secondary Research Sources    
  2.5.3 Assumptions     
         
3 Market Trend Analysis      
 3.1 Introduction      
 3.2 Drivers       
 3.3 Restraints      
 3.4 Opportunities      
 3.5 Threats       
 3.6 End User Analysis       
 3.7 Emerging Markets      
         
4 Porters Five Force Analysis      
 4.1 Bargaining power of suppliers     
 4.2 Bargaining power of buyers     
 4.3 Threat of substitutes     
 4.4 Threat of new entrants     
 4.5 Competitive rivalry      
         
5 Global Bronchitis Treatment Market, By Class of Drugs   
 5.1 Introduction       
 5.2 Bronchodilators      
 5.3 Mucolytics      
 5.4 Antibiotics      
 5.5 Anti-inflammatory Drugs     
         
6 Global Bronchitis Treatment Market, By Treatment    
 6.1 Introduction       
 6.2 Oxygen therapy      
 6.3 Drugs       
         
7 Global Bronchitis Treatment Market, By End User    
 7.1 Introduction       
 7.2 Drug stores      
 7.3 Hospitals       
 7.4 Clinics       
         
8 Global
Bronchitis Treatment Market, By Geography    
 8.1 North America      
  8.1.1 US      
  8.1.2 Canada      
  8.1.3 Mexico      
 8.2 Europe       
  8.2.1 Germany      
  8.2.2 France      
  8.2.3 Italy      
  8.2.4 UK      
  8.2.5 Spain      
  8.2.6 Rest of Europe     
 8.3 Asia Pacific      
  8.3.1 Japan      
  8.3.2 China      
  8.3.3 India      
  8.3.4 Australia      
  8.3.5 New Zealand     
  8.3.6 Rest of Asia Pacific     
 8.4 Rest of the World      
  8.4.1 Middle East     
  8.4.2 Brazil      
  8.4.3 Argentina     
  8.4.4 South Africa     
  8.4.5 Egypt      
         
9 Key Developments    
   
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures  
 9.2 Acquisitions & Mergers     
 9.3 New Product Launch     
 9.4 Expansions      
 9.5 Other Key Strategies     
         
10 Company Profiling       
10.1 GlaxoSmithKline Pharmaceuticals Limited
10.2 Boehringer Ingelheim
10.3 Osiris Therapeutics, Inc.
10.4 Pfizer Inc.
10.5 Reddy’s Laboratories Ltd
10.6 Sanofi Aventis
10.7 Hyundai Pharmaceutical Co., Ltd.
10.8 Mucosis B.V.
10.9 Myelo Therapeutics GmbH
10.10 DBV Technologies S.A.
10.11 Recipharm
10.12 Dr. Reddy’s Laboratories Ltd


List of Tables        
1 Global Bronchitis Treatment Market Outlook, By Region (2013-2022) ($MN) 
2 Global Bronchitis Treatment Market Outlook, By Class of Drugs (2013-2022) ($MN) 
3 Global Bronchitis Treatment Market Outlook, By Bronchodilators (2013-2022) ($MN)
4 Global Bronchitis Treatment Market Outlook, By Mucolytics (2013-2022) ($MN) 
5 Global Bronchitis Treatment Market Outlook, By Antibiotics (2013-2022) ($MN) 
6 Global Bronchitis Treatment Market Outlook, By Anti-inflammatory Drugs (2013-2022) ($MN)
7 Global Bronchitis Treatment Market Outlook, By Treatment (2013-2022) ($MN) 
8 Global Bronchitis Treatment Market Outlook, By Oxygen therapy (2013-2022) ($MN)
9 Global Bronchitis Treatment Market Outlook, By Drugs (2013-2022) ($MN) 
10 Global Bronchitis Treatment Market Outlook, By End User (2013-2022) ($MN) 
11 Global Bronchitis Treatment Market Outlook, By Drug stores (2013-2022) ($MN) 
12 Global Bronchitis Treatment Market Outlook, By Hospitals (2013-2022) ($MN) 
13 Global Bronchitis Treatment Market Outlook, By Clinics (2013-2022) ($MN) 
14 North America Bronchitis Treatment Market Outlook, By Class of Drugs (2013-2022) ($MN)
15 North America Bronchitis Treatment Market Outlook, By Bronchodilators (2013-2022) ($MN)
16 North America Bronchitis Treatment Market Outlook, By Mucolytics (2013-2022) ($MN)
17 North America Bronchitis Treatment Market Outlook, By Antibiotics (2013-2022) ($MN)
18 North America Bronchitis Treatment Market Outlook, By Anti-inflammatory Drugs (2013-2022) ($MN)
19 North America Bronchitis Treatment Market Outlook, By Treatment (2013-2022) ($MN)
20 North America Bronchitis Treatment Market Outlook, By Oxygen therapy (2013-2022) ($MN)
21 North America Bronchitis Treatment Market Outlook, By Drugs (2013-2022) ($MN) 
22 North America Bronchitis Treatment Market Outlook, By End User (2013-2022) ($MN)
23 North America Bronchitis Treatment Market Outlook, By Drug stores (2013-2022) ($MN)
24 North America Bronchitis Treatment Market Outlook, By Hospitals (2013-2022) ($MN)
25 North America Bronchitis Treatment Market Outlook, By Clinics (2013-2022) ($MN) 
26 Europe Bronchitis Treatment Market Outlook, By Class of Drugs (2013-2022) ($MN) 
27 Europe Bronchitis Treatment Market Outlook, By Bronchodilators (2013-2022) ($MN)
28 Europe Bronchitis Treatment Market Outlook, By Mucolytics (2013-2022) ($MN) 
29 Europe Bronchitis Treatment Market Outlook, By Antibiotics (2013-2022) ($MN) 
30 Europe Bronchitis Treatment Market Outlook, By Anti-inflammatory Drugs (2013-2022) ($MN)
31 Europe Bronchitis Treatment Market Outlook, By Treatment (2013-2022) ($MN) 
32 Europe Bronchitis Treatment Market Outlook, By Oxygen therapy (2013-2022) ($MN)
33 Europe Bronchitis Treatment Market Outlook, By Drugs (2013-2022) ($MN) 
34 Europe Bronchitis Treatment Market Outlook, By End User (2013-2022) ($MN) 
35 Europe Bronchitis Treatment Market Outlook, By Drug stores (2013-2022) ($MN) 
36 Europe Bronchitis Treatment Market Outlook, By Hospitals (2013-2022) ($MN) 
37 Europe Bronchitis Treatment Market Outlook, By Clinics (2013-2022) ($MN) 
38 Asia Pacific Bronchitis Treatment Market Outlook, By Class of Drugs (2013-2022) ($MN)
39 Asia Pacific Bronchitis Treatment Market Outlook, By Bronchodilators (2013-2022) ($MN)
40 Asia Pacific Bronchitis Treatment Market Outlook, By Mucolytics (2013-2022) ($MN)
41 Asia Pacific Bronchitis Treatment Market Outlook, By Antibiotics (2013-2022) ($MN)
42 Asia Pacific Bronchitis Treatment Market Outlook, By Anti-inflammatory Drugs (2013-2022) ($MN)
43 Asia Pacific Bronchitis Treatment Market Outlook, By Treatment (2013-2022) ($MN)
44 Asia Pacific Bronchitis Treatment Market Outlook, By Oxygen therapy (2013-2022) ($MN)
45 Asia Pacific Bronchitis Treatment Market Outlook, By Drugs (2013-2022) ($MN) 
46 Asia Pacific Bronchitis Treatment Market Outlook, By End User (2013-2022) ($MN) 
47 Asia Pacific Bronchitis Treatment Market Outlook, By Drug stores (2013-2022) ($MN)
48 Asia Pacific Bronchitis Treatment Market Outlook, By Hospitals (2013-2022) ($MN) 
49 Asia Pacific Bronchitis Treatment Market Outlook, By Clinics (2013-2022) ($MN) 
50 Rest of the World Bronchitis Treatment Market Outlook, By Class of Drugs (2013-2022) ($MN)
51 Rest of the World Bronchitis Treatment Market Outlook, By Bronchodilators (2013-2022) ($MN)
52 Rest of the World Bronchitis Treatment Market Outlook, By Mucolytics (2013-2022) ($MN)
53 Rest of the World Bronchitis Treatment Market Outlook, By Antibiotics (2013-2022) ($MN)
54 Rest of the World Bronchitis Treatment Market Outlook, By Anti-inflammatory Drugs (2013-2022) ($MN)
55 Rest of the World Bronchitis Treatment Market Outlook, By Treatment (2013-2022) ($MN)
56 Rest of the World Bronchitis Treatment Market Outlook, By Oxygen therapy (2013-2022) ($MN)
57 Rest of the World Bronchitis Treatment Market Outlook, By Drugs (2013-2022) ($MN)
58 Rest of the World Bronchitis Treatment Market Outlook, By End User (2013-2022) ($MN)
59 Rest of the World Bronchitis Treatment Market Outlook, By Drug stores (2013-2022) ($MN)
60 Rest of the World Bronchitis Treatment Market Outlook, By Hospitals (2013-2022) ($MN)
61 Rest of the World Bronchitis Treatment Market Outlook, By Clinics (2013-2022) ($MN)

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials